Cognitive enhancing effects of an AMPA receptor positive modulator on place learning in mice

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 18-25

  Malá, Hana ^a   Chen, Yuxia ^b   Worm, Vivi Hu ^b   Kure, Julie ^b   Kaae, Birgitte H ^b   Madsen, Ulf ^b   Badolo, Lassina ^b   Pickering, Darryl S ^b   Mogensen, Jesper ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acquisition; AMPA receptor potentiator; Biarylpropylsulfonamide; Cognitive enhancement; Mice; Place learning; Scopolamine; Water maze

Indexed keywords

AMPA RECEPTOR AGONIST; N,N (2,20 [BIPHENYL 4 40 DIYL]BIS[PROPANE 2,1 DIYL])DIMETHANESULFONAMIDE; NOOTROPIC AGENT; SCOPOLAMINE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; COGNITION; CONTROLLED STUDY; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG TARGETING; HABITUATION; LEARNING; MALE; MAXIMUM PLASMA CONCENTRATION; MAZE TEST; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SPATIAL DISCRIMINATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIPHENYL COMPOUNDS; COGNITION; MALE; MAZE LEARNING; MICE; MUSCARINIC ANTAGONISTS; NOOTROPIC AGENTS; RECEPTORS, AMPA; SCOPOLAMINE HYDROBROMIDE; SULFONAMIDES;

EID: 80053175336     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.08.036     Document Type: Article

References (49)

1. Bannerman D.N., Rawlins J.N., Good M.A. The drugs don't work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory. Psychopharmacology (Berl) 2006, 188:552-566.
2. Bleich S., Romer K., Wiltfang J., Kornhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 2003, 18:S33-S40.
3. Bowie D. Ionotropic glutamate receptors and CNS disorders. CNS Neurol Disord Drug Targets 2008, 7:129-143.
4. Chappell A.S., Gonzales C., Williams J., Witte M.M., Mohs R.C., Sperling R. AMPA potentiator treatment of cognitive deficits in Alzheimer disease. Neurology 2007, 68:1008-1012.
5. Farley S., Apazoglou K., Witkin J.M., Giros B., Tzavara E.T. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 2010, 13:1207-1218.
6. Fellini L., Schachner M., Morellini F. Adult but not aged C57BL/6 male mice are capable of using geometry for orientation. Learn Mem 2006, 13:473-481.
7. Frick K.M., Stillner E.T., Berger-Sweeney J. Mice are not little rats: species differences in a one-day water maze task. Neuroreport 2000, 11:3461-3465.
8. Hodges D.B., Lindner M.D., Hogan J.B., Jones K.M., Markus E.J. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity. Behav Pharmacol 2009, 20:237-251.
9. Itami C., Kimura F., Kohno T., Matsuoka M., Ichikawa M., Tsumoto T., et al. Brain-derived neurotrophic factor-dependent unmasking of silent synapses in the developing mouse barrel cortex. Proc Natl Acad Sci USA 2003, 100:13069-13074.
10. Jhee S.S., Chappell A.S., Zarotsky V., Moran S.V., Rosenthal M., Kim E., et al. Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects. J Clin Pharmacol 2006, 46:424-432.
11. Kaae B.H., Harpsoe K., Kastrup J.S., Sanz A.C., Pickering D.S., Metzler B., et al. Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites. Chem Biol 2007, 14:1294-1303.
12. Kallai J., Makany T., Csatho A., Karadi K., Horvath D., Kovacs-Labadi B., et al. Cognitive and affective aspects of thigmotaxis strategy in humans. Behav Neurosci 2007, 121:21-30.
13. Kerchner G.A., Nicoll R.A. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci 2008, 9:813-825.
14. Lamberty Y., Gower A.J. Cholinergic modulation of spatial learning in mice in a Morris-type water maze. Arch Int Pharmacodyn Ther 1991, 309:5-19.
15. Li W., Keifer J. Coordinate action of pre- and postsynaptic brain-derived neurotrophic factor is required for AMPAR trafficking and acquisition of in vitro classical conditioning. Neuroscience 2008, 155:686-697.
16. Li X., Tizzano J.P., Griffey K., Clay M., Lindstrom T., Skolnick P. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 2001, 40:1028-1033.
17. McDonald J.F., Jackson M.F., Beazely M.A. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 2006, 18:71-84.
18. McKinney R.A. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol 2010, 588:107-116.
19. Mogensen J. Almost unlimited potentials of a limited neural plasticity: levels of plasticity in development and reorganization of the injured brain. J Conscious Stud 2011, 18:13-45.
20. Mogensen J. Animal models in neuroscience. Animal models 2011, vol. II:47-73. CRC Press LLC, Boca Raton, FL. third ed. J. Hau, S.J. Schapiro (Eds.).
21. Mogensen J. Reorganization in the injured brain: implications for studies of the neural substrate of cognition. Front Psychol 2011, 2(7):1-10.
22. Mogensen J., Christensen L.H., Johansson A., Wörtwein G., Bang L.E., Holm S. Place learning in scopolamine-treated rats: the roles of distal cues and catecholaminergic mediation. Neurobiol Learn Mem 2002, 78:139-166.
23. Mogensen J., Lauritsen K.T., Elvertorp S., Hasman A., Moustgaard A., Wörtwein G. Place learning and object recognition by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull 2004, 63:217-236.
24. Mogensen J., Malá H. Post-traumatic functional recovery and reorganization in animal models. A theoretical and methodological challenge. Scand J Psychol 2009, 50:561-573.
25. Mogensen J., Moustgaard A., Khan U., Wörtwein G., Nielsen K.S. Egocentric spatial orientation in a water maze by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull 2005, 65:41-58.
26. Mogensen J., Wörtwein G., Hasman A., Nielsen P., Wang Q. Functional and neurochemical profile of place learning after l-nitro-arginine in the rat. Neurobiol Learn Mem 1995, 63:54-65.
27. Mogensen J., Wörtwein G., Plenge P., Mellerup E.T. Serotonin, locomotion, exploration, and place recall in the rat. Pharmacol Biochem Behav 2003, 75:381-395.
28. Morris R. Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
29. Murray T.K., Whalley K., Robinson C.S., Ward M.A., Hicks C.A., Lodge D., et al. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazzole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. J Pharmacol Exp Ther 2003, 306:752-762.
30. Nieto-Escamez F.A., Sanchez-Santed F., de Bruin J.P. Cholinergic receptor blockade in prefrontal cortex and lesions of the nucleus basalis: implications for allocentric and egocentric spatial memory in rats. Behav Brain Res 2002, 134:93-112.
31. O'Neill M.J., Bleakman D., Zimmerman D.M., Nisenbaum E.S. AMPA receptor potentiators for the treatment of CNS disorders. Curr Drug Targets CNS Neurol Disord 2004, 3:181-194.
32. O'Neill M.J., Dix S. AMPA receptor potentiators as cognitive enhancers. IDrugs 2007, 10:185-192.
33. O'Neill M.J., Witkin J.M. AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets 2007, 8:603-620.
34. Olton D.S., Papas B.C. Spatial memory and hippocampal function. Neuropsychologia 1979, 17:669-682.
35. Ornstein P.L., Zimmerman D.M., Arnold M.B., Bleisch T.J., Cantrell B., Simon R., et al. Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptors. J Med Chem 2000, 43:4354-4358.
36. Parsons C.G., Stöffler A., Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 2007, 53:699-723.
37. Quirk J.C., Nisenbaum E.S. LY404187: a novel positive allosteric modulator of AMPA receptors. CNS Drug Rev 2002, 8:255-282.
38. Riedel G., Micheau J., Lam A.G., Roloff E.L., Martin S.J., Bridge H., et al. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat Neurosci 1999, 2:898-905.
39. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003, 140:1-47.
40. Robbins T.W., Murphy E.R. Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition. Trends Pharmacol Sci 2006, 27:141-148.
41. Sanderson D.J., Good M.A., Seeburg P.H., Sprengel R., Rawlins J.N., Bannerman D.M. The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory. Prog Brain Res 2008, 169:159-178.
42. Santos S.D., Carvalho A.L., Caldeira M.V., Duarte C.D. Regulation of AMPA receptors and synaptic plasticity. Neuroscience 2009, 158:105-125.
43. Souza A.C.G., Brüning C.A., Leite M.R., Zeni G., Nogueira C.W. Diphenyl diselenide improves scopolamine-induced memory impairment in mice. Behav Pharmacol 2010, 21:556-562.
44. Taffe M.A., Weed M.R., Gold L.H. Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res 1999, 8:203-212.
45. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988, 31:959-962.
46. Upchurch M., Wehner J.M. Differences between inbred strains of mice in Morris water maze performance. Behav Genet 1988, 18:55-68.
47. von Linstow Roloff E., Harbaran D., Micheau J., Platt B., Riedel G. Dissociation of cholinergic function in spatial and procedural learning in rats. Neuroscience 2007, 146:875-889.
48. Ward S.E., Bax B.D., Harries M. Challenges for and current status of research into positive modulators of AMPA receptors. Br J Pharmacol 2010, 160:181-190.
49. Zarate C.A., Manji H.K. The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Exp Neurol 2008, 211:7-10.